Jansen Burkhard 4
4 · DermTech, Inc. · Filed Jan 16, 2020
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Jansen Burkhard
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-01-14+43,120→ 43,120 totalExercise: $9.73Exp: 2030-01-14→ Common Stock (43,120 underlying)
Footnotes (1)
- [F1]The shares of Issuer common stock exercisable pursuant to this option shall vest in a series of thirty-six (36) successive equal monthly installments commencing one month following January 14, 2020, such that all shares of Issuer common stock exercisable pursuant to this option shall be fully vested on January 14, 2023, subject to the Reporting Person's continued service.